In a world where digital technology is significantly changing the way patients experience their care, UCB recognized the need for rapid integration of digital innovation into all aspects of business. Read from Emmanuel Caeymaex, Executive Vice President, Immunology Solutions and Head of U.S., on how UCB quickly adapted to the needs of patients and the ever-changing environment by embracing a digital business transformation.

This Employee Appreciation Day, we’re celebrating UCB employees for their unique talents and how they positively impact the lives of the patients we serve. Read from employees, Kassandra Watson and Chris Bess, about how UCB’s culture encourages them to be their authentic self at work.

Last week, UCB released our Integrated Annual Report. 2020 was an exceptional year influenced by exceptional circumstances. Read how we are leveraging our expertise to integrate sustainability into our business approach and improve societal health. 

This Rare Disease Day, we’re continuing to raise awareness about seeing people in need and our commitment to innovating and finding solutions for patients living with rare diseases. 

Today, UCB announced seven U.S-based organizations received support from the UCB Community Health Fund managed by the King Baudouin Foundation in Belgium.

2020 tested many long-held beliefs and practices of how we work, how we think about our health, and how we help others. Read more from UCB's Chief Executive Officer & Chairman of the Executive Committee, Jean-Christophe Tellier, as he reflects on the lessons learned and our work to improve the lives of patients now and to create a healthier future.